Aloe Blacc’s fame means nothing in biotech (and that’s the point) | TechCrunch
…Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of its patients, and intentionally waiting to raise from his network until peer-reviewed papers can…
